CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Suspect Technologies Raises $810K for Facial Recognition Products

From Biometric Update

December 14, 2018

Suspect Technologies Raises $810K for Facial Recognition Products

Suspect Technologies Raises $810K for Facial Recognition Products
Suspect Technologies closed an $810,000 funding round led by Mark Cuban and Chaac Ventures, according to Xconomy. The Cambridge, Massachusetts-based facial recognition startup plans to launch new suspect and watch list identification products over the next year.\n\nThe company was founded in 2015 by Jacob Sniff and MIT researcher Srikanth Parupati. It provides facial redaction software to police body camera makers and is piloting facial recognition technology internationally. Cuban had the technology installed at the entrance to the Dallas Mavericks locker room after making a previous investment. Suspect Technologies hoped to grow from six employees to ten in the first half of 2019 and raise a larger funding round next year.

View original article on biometricupdate.com

Most Recent

KymaThera Raises $80M to Advance K-1728 PI3Kα Inhibitor

KymaThera has closed an $80 million Series B financing to advance its lead investigational candidate, K-1728, toward clinical development.

Oct 6, 2026

Vantora Secures More Than $100 Million From Silversmith Capital Partners to Build AI-Native Operating Companies Inside Industrial Enterprises

Vantora announced more than $100 million in growth investment from Silversmith Capital Partners to back its model of building AI-native operating companies inside industrial enterprises.

Sep 15, 2026

Complir Raises $11M Seed

Copenhagen-based Complir raises $11M in seed funding led by General Catalyst to expand its AI-driven product compliance platform for global retailers.

Sep 15, 2026

Mithrl Raises $20M to Bring Custom AI Infrastructure to Biopharma, Grounded in Its Biomedical World Model

Mithrl announced a $20 million Series A led by Obvious Ventures, with participation from Headline, AGI House, and several pharma executives.

Sep 15, 2026

Similar Posts

Face Redaction Startup Suspect Technologies Plans to Enter Facial Recognition Market

Suspect Technologies is planning a funding round to expand from facial redaction products to facial recognition systems for law enforcement agencies, with backing from Mark Cuban.

Feb 28, 2018

Data Collection Practices of Facial Biometrics Companies Criticized

Suspect Technologies drew criticism for attempting to deploy facial recognition technology publicly and gain access to the Massachusetts driver license image database, according to emails obtained by the ACLU and reported by Motherboard.

May 7, 2019

Workplace fraud monitoring startup Yardstik raises $30M to help employers keep tabs on their staff

Yardstik Inc., a workforce screening startup that monitors companies’ employees for potential fraudulent actions, said today it has closed on a $30 million growth round of funding that brings its total amount raised to date to $65 million. Harbert Growth Partners led the Series B round, which also s

Aug 27, 2026

Nuance Labs bags $50M in funding to fix the awkwardness of AI avatars

Nuance Labs, a Seattle-based startup that’s trying to make artificial intelligence models better at face-to-face conversations, said today it has closed on a $50 million early-stage funding round to make that happen. Today’s Series A round was led by Lightspeed Venture Partners, which previously bac

Sep 14, 2026